Eventide Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-164,299	Closed	-$14.5M	–	157
2023 Q3	$14.5M	Hold	164,299	–	–	0.26%	103
2023 Q2	$14.2M	Hold	164,299	–	–	0.24%	104
2023 Q1	$16M	Sell	164,299 -65,701	-29%	-$6.81M	0.29%	94
2022 Q4	$23.8M	Buy	+230,000	New	+$21.6M	0.47%	69
2018 Q4	–	Sell	-132,000	Closed	-$12.8M	–	140
2018 Q3	$12.8M	Buy	132,000 +57,000	+76%	+$5.69M	0.47%	67
2018 Q2	$7.07M	Hold	75,000	–	–	0.29%	86
2018 Q1	$6.08M	Hold	75,000	–	–	0.28%	86
2017 Q4	$6.69M	Hold	75,000	–	–	0.35%	78
2017 Q3	$6.98M	Hold	75,000	–	–	0.4%	69
2017 Q2	$6.81M	Hold	75,000	–	–	0.42%	61
2017 Q1	$6.58M	Hold	75,000	–	–	0.44%	62
2016 Q4	$6.21M	Hold	75,000	–	–	0.4%	63
2016 Q3	$6.94M	Hold	75,000	–	–	0.42%	63
2016 Q2	$5.83M	Hold	75,000	–	–	0.36%	68
2016 Q1	$6.19M	Hold	75,000	–	–	0.35%	67
2015 Q4	$7.86M	Sell	75,000 -5,400	-7%	-$564K	0.39%	65
2015 Q3	$8.47M	Buy	80,400 +28,600	+55%	+$3.82M	0.49%	58
2015 Q2	$7.08M	Buy	51,800 +11,700	+29%	+$1.45M	0.38%	65
2015 Q1	$5M	Buy	40,100 +9,900	+33%	+$1.05M	0.38%	69
2014 Q4	$2.73M	Hold	30,200	–	–	0.3%	70
2014 Q3	$2.18M	Hold	30,200	–	–	0.3%	69
2014 Q2	$1.88M	Buy	30,200 +2,100	+7%	+$127K	0.26%	78
2014 Q1	$1.92M	Buy	28,100 +17,700	+170%	+$1.3M	0.3%	70
2013 Q4	$731K	Buy	+10,400	New	+$706K	0.23%	68